Journal Title：Molecular Omics

Molecular Omics publishes high-quality research from across the -omics sciences.

Topics include, but are not limited to:

-omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance

-omics studies for clinical applications with validation, such as finding biomarkers for diagnostics or potential new drug targets

-omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques

-studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field.

Molecular Omics only accepts articles of high importance and interest that provide significant new insight into important chemical or biological problems. This could be fundamental research that significantly increases understanding or research that demonstrates clear functional benefits.

Papers reporting new results that could be routinely predicted, do not show a significant improvement over known research, or are of interest only to the specialist in the area are not suitable for publication in Molecular Omics.

《分子組學》出版了來自組學科學各個領域的高質量研究。

主題包括但不限于：

-組學研究旨在深入了解生物過程的機制 - 例如，確定藥物的作用方式或特定表型的基礎，如耐旱性

-經過驗證的臨床應用組學研究，例如尋找診斷的生物標志物或潛在的新藥靶點

-組學研究著眼于細胞的亞細胞組成 - 例如，某些蛋白質的亞細胞定位或翻譯后修飾或新的成像技術

-提出支持組學研究的新方法和工具的研究，包括新的光譜/色譜技術、基于芯片/陣列的技術和新的分類/數據分析技術。新方法應經過驗證并展示該領域的進步。

《分子組學》僅接受具有高度重要性和吸引力的文章，這些文章可為重要的化學或生物問題提供重要的新見解。這可能是顯著增加理解的基礎研究，也可能是展示明顯功能優(yōu)勢的研究。

報告新結果的論文不適合在《分子組學》上發(fā)表，這些新結果可以常規(guī)預測，與已知研究相比沒有顯著改進，或者僅引起該領域專家的興趣。

Molecular Omics由Royal Society of Chemistry出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Biochemistry全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 Time to first decision: 20.0 days ，影響因子指數3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。